☆ 4.7 Editorial Material

Targeting NF-κB in Mouse Models of Lung Adenocarcinoma

CANCER DISCOVERY (2011)

期刊

CANCER DISCOVERY

卷 1, 期 3, 页码 200-202

出版社

AMER ASSOC CANCER RESEARCH

DOI: 10.1158/2159-8290.CD-11-0159

关键词

-

类别

Oncology

资金

Intramural NIH HHS [ZIA DC000016-19] Funding Source: Medline

向作者/读者索取更多资源

Protocol

Reagent

摘要

Xue et al. demonstrate response and increased survival but development of acquired resistance to proteasome and inhibitor-kappa B kinase inhibitors targeting NF-kappa B activation in adenocarcinomas of Kras-activated, p53-deficient mice. Cancer Discovery; 1(3):200-2. (C) 2011 AACR.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Plant Sciences

Cinobufacini retards progression of pancreatic ductal adenocarcinoma through targeting YEATS2/TAK1/NF-κB axis

Tian Lan, Hang-fei Chen, Fang Zheng, Hui Huang, Qi Wu, Xue-yu Fan, Si-wei Wang, Feng Zhang

Summary: Cinobufacini was found to inhibit the progression of pancreatic ductal adenocarcinoma by modulating the YEATS2/TAK1/NF-kappa B pathway. The results demonstrated that cinobufacini can induce cell cycle arrest and inhibit the growth of pancreatic cancer cells, as well as suppress tumor progression in mice.

PHYTOMEDICINE (2023)

添加到收藏夹

Review Cell Biology

Role of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models

Veronica A. Garcia-Garcia, Josefa P. Alameda, Angustias Page, Maria Llanos Casanova

Summary: Ageing is a complex process influenced by genetic, epigenetic, and environmental factors, associated with decline in physiological functions, chronic diseases, and cancer development. NF-κB acts as a crucial mediator of chronic inflammation, implicated in driving the ageing process. Activation or inhibition of NF-κB can impact the main features of aged organisms.

CELLS (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma

Daniel A. Rauch, John C. Harding, Lee Ratner, Samuel A. Wickline, Hua Pan

Summary: Adult T-cell leukemia/lymphoma (ATLL) is a rare but highly malignant tumor caused by human T-cell leukemia virus type 1. A nano-delivery system was developed to inhibit NF-kappa B signaling pathways in tumors by delivering siRNA, resulting in significant tumor growth inhibition and enhanced sensitivity to chemotherapy in late-stage ATLL tumors.

NANOMATERIALS (2021)

添加到收藏夹

Article Oncology

Transmembrane p24 trafficking protein 2 regulates inflammation through the TLR4/NF-κB signaling pathway in lung adenocarcinoma

Longhua Feng, Pengjiang Cheng, Zhengyun Feng, Xiaoyu Zhang

Summary: The overexpression of TMED2 in LUAD is negatively correlated with malignant survival and apoptosis. Knockdown of TMED2 inhibits LUAD development and increases the levels of inflammatory factors. In addition, TMED2 is associated with TME-associated immune cells, their target markers, and some mechanisms and pathways.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Targeting HSPA1A in ARID2-deficient lung adenocarcinoma

Xue Wang, Yuetong Wang, Zhaoyuan Fang, Hua Wang, Jian Zhang, Longfu Zhang, Hsinyi Huang, Zhonglin Jiang, Yujuan Jin, Xiangkun Han, Shenda Hou, Bin Zhou, Feilong Meng, Luonan Chen, Kwok-Kin Wong, Jinfeng Liu, Zhiqi Zhang, Xin Zhang, Haiquan Chen, Yihua Sun, Liang Hu, Hongbin Ji

Summary: Somatic mutations of the chromatin remodeling gene ARID2 are found in around 7% of human lung adenocarcinomas, and its decreased expression is associated with lung cancer malignant progression. Knockout of ARID2 significantly promotes lung cancer progression, while knockdown of Hspa1a specifically inhibits malignant progression of ARID2-deficient lung cancers. Treatment with an HSPA1A inhibitor could significantly inhibit the malignant progression of lung cancer with ARID2 deficiency.

NATIONAL SCIENCE REVIEW (2021)

添加到收藏夹

Article Endocrinology & Metabolism

SPON2 promotes the bone metastasis of lung adenocarcinoma via activation of the NF-ΚB signaling pathway

Ming Wu, Dewei Kong, Yan Zhang

Summary: Bone metastasis is a major complication in lung adenocarcinoma (ADC) patients, and identifying biomarkers for this disease is crucial. This study found that SPON2 plays a key role in promoting bone metastasis by activating the NF-kappa B pathway in ADC. These findings suggest that SPON2 could be a potential therapeutic target for future drug development.

BONE (2023)

添加到收藏夹

Article Cell Biology

Novel small molecule inhibition of IKK/NF-κB activation reduces markers of senescence and improves healthspan in mouse models of aging

Lei Zhang, Jing Zhao, Xiaodong Mu, Sara J. McGowan, Luise Angelini, Ryan D. O'Kelly, Matthew J. Yousefzadeh, Ayumi Sakamoto, Zaira Aversa, Nathan K. LeBrasseur, Yousin Suh, Johnny Huard, Theodore M. Kamenecka, Laura J. Niedernhofer, Paul D. Robbins

Summary: Inhibiting NF-κ B activation with SR12343 shows promising results in reducing cellular senescence markers, improving muscle fiber size, and extending healthy lifespan. The therapeutic effects of SR12343 were observed in different mouse models, suggesting it as a potential treatment for reducing cellular senescence and aging-related diseases.

AGING CELL (2021)

添加到收藏夹

Article Respiratory System

FUT3 facilitates glucose metabolism of lung adenocarcinoma via activation of NF-κB pathway

Lanlan Lin, Xiaohui Chen, Guofu Lin, Luyang Chen, Yuan Xu, Yiming Zeng

Summary: This study found that FUT3 is significantly upregulated in LUAD tissues, and high expression of FUT3 may predict poor prognosis in LUAD patients. Knockdown of FUT3 can significantly inhibit tumor proliferation, migration, and glucose metabolism alterations in LUAD cells. Furthermore, FUT3 upregulation is positively correlated with the NF-kappa B signaling pathway, and downregulation of FUT3 leads to inhibition of oncogenesis and glucose metabolism through inactivation of the NF-kappa B pathway.

BMC PULMONARY MEDICINE (2023)

添加到收藏夹

Review Pharmacology & Pharmacy

Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma

Md Sahab Uddin, Md Tanvir Kabir, Abdullah Al Mamun, Md Shahid Sarwar, Fatema Nasrin, Talha Bin Emran, Ibtesam S. Alanazi, Abdur Rauf, Ghadeer M. Albadrani, Amany A. Sayed, Shaker A. Mousa, Mohamed M. Abdel-Daim

Summary: NF-κB is a critical transcription factor that is abnormally activated in several cancers, particularly in glioblastoma multiforme (GBM). Despite the use of various treatment modalities for GBM, the survival rate of patients remains low, highlighting the need for new therapeutic approaches.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Engineering, Chemical

Coleus aromaticus Ethanolic Leaves Extract Mediates Inhibition of NF-κB Signaling Pathway in Lung Adenocarcinoma A549 Cells

Gehad Subaiea, Ahmed Alafnan, Abdulwahab Alamri, Talib Hussain, Shimaa Mahmoud Hassoun, Amr Selim Abu Lila, El-Sayed Khafagy, Ahmed A. A. Katamesh

Summary: "Umo Ishi" is a novel written by Kenzaburo Oe, in which the author reflects on and pursues peace and justice through a review of history and reality. Set against the backdrop of the Chinese resistance during World War II, the novel portrays the devastation of war on ordinary people and the distortion of human nature through the lives and inner monologues of different characters. By depicting the brutality of war and the complexity of human nature, the novel explores the meaning and impact of war on humanity, and calls for the pursuit of peace.

PROCESSES (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Brevilin A Ameliorates Acute Lung Injury and Inflammation Through Inhibition of NF-κB Signaling via Targeting IKKα/β

Lu Liu, Xian Chen, Yifang Jiang, Yun Yuan, Luyao Yang, Qiongying Hu, Jianyuan Tang, Xianli Meng, Chunguang Xie, Xiaofei Shen

Summary: In this study, the researchers found that Brevilin A can inhibit lung injury and has anti-inflammatory activity. Brevilin A achieves the effect of improving acute lung injury by inhibiting the production of inflammatory factors and the activation of the NF-kappa B signaling pathway.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Oncology

UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells

Jhih-Yun Ho, Hsin-Ying Lu, Hsing-Hsien Cheng, Yu-Chieh Kuo, Yu-Lin Amy Lee, Chia-Hsiung Cheng

Summary: The study showed that higher UBE2S expression in lung adenocarcinomas leads to increased binding with I kappa B alpha to activate NF-kappa B signaling and promote adenocarcinoma cell metastasis. UBE2S may serve as a potential therapeutic target for lung adenocarcinomas.

CELLULAR ONCOLOGY (2021)

添加到收藏夹

Article Oncology

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma

Jinsheng Ding, Hui Li, Yang Liu, Yongjie Xie, Jie Yu, Huizhi Sun, Di Xiao, Yizhang Zhou, Li Bao, Hongwei Wang, Chuntao Gao

Summary: This study identified OXCT1 as a key gene leading to GEM resistance in PDAC through the NF-kappa B signaling pathway, with high OXCT1 expression associated with shorter relapse-free survival under GEM treatment. OXCT1 overexpression in PDAC cell lines inhibited apoptosis after GEM treatment, and blocking the NF-kappa B signaling pathway reduced GEM resistance. These findings suggest that OXCT1 could be a potential therapeutic target for patients with PDAC.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Plant Sciences

Corylin inhibits the progression of Non-small cell lung cancer cells by regulating NF-κB signaling pathway via targeting p65

Zihan Lin, Lijuan Liao, Shengchao Zhao, Wei Gu, Guanzhen Wang, Ziyi Shen, Yuanhui Wang, Kun Chen, Wei Liu, Yi Cai, Chunpeng Wan, Tingdong Yan

Summary: The study found that corylin is a substance that inhibits the progression of non-small cell lung cancer cells, and it inhibits the NF-kappa B signaling pathway by blocking p65 nuclear translocation. The study provides a novel strategy for improving the prognosis and treatment of non-small cell lung cancer patients.

PHYTOMEDICINE (2023)

添加到收藏夹

Article Cell Biology

Aryl Hydrocarbon Receptor (AhR) Limits the Inflammatory Responses in Human Lung Adenocarcinoma A549 Cells via Interference with NF-κB Signaling

Gerardo Vazquez-Gomez, Martina Karasova, Zuzana Tylichova, Marketa Kabatkova, Ales Hampl, Jason Matthews, Jiri Neca, Miroslav Ciganek, Miroslav Machala, Jan Vondracek

Summary: In this study, the functional role of AhR in controlling inflammatory responses was examined using A549 cells. It was found that AhR acts as a negative regulator of inflammation by modulating NF-κB signaling.

CELLS (2022)

添加到收藏夹

暂无数据

暂无数据

© Peeref 2019-2024. All rights reserved.